EDWARDS LIFESCIENCES CORP (EWL.DE) Stock Fundamental Analysis
Europe - Frankfurt Stock Exchange - FRA:EWL - US28176E1082 - Common Stock
73.34 EUR
+1.48 (+2.06%)
We assign a fundamental rating of 7 out of 10 to EWL. EWL was compared to 65 industry peers in the Health Care Equipment & Supplies industry. EWL has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. EWL is valied quite expensively at the moment, while it does show a decent growth rate. These ratings would make EWL suitable for quality investing!
1. Profitability
1.1 Basic Checks
EWL had positive earnings in the past year.
In the past year EWL had a positive cash flow from operations.
In the past 5 years EWL has always been profitable.
In the past 5 years EWL always reported a positive cash flow from operatings.
1.2 Ratios
EWL has a better Return On Assets (10.31%) than 86.15% of its industry peers.
EWL's Return On Equity of 13.40% is fine compared to the rest of the industry. EWL outperforms 73.85% of its industry peers.
Looking at the Return On Invested Capital, with a value of 9.83%, EWL is in the better half of the industry, outperforming 73.85% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for EWL is above the industry average of 10.04%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.31% | ||
| ROE | 13.4% | ||
| ROIC | 9.83% |
ROA(3y)21.77%
ROA(5y)18.87%
ROE(3y)29.68%
ROE(5y)26.56%
ROIC(3y)12.44%
ROIC(5y)13.58%
1.3 Margins
The Profit Margin of EWL (23.25%) is better than 89.23% of its industry peers.
EWL's Profit Margin has improved in the last couple of years.
With an excellent Operating Margin value of 27.73%, EWL belongs to the best of the industry, outperforming 95.38% of the companies in the same industry.
EWL's Operating Margin has been stable in the last couple of years.
EWL has a better Gross Margin (78.19%) than 92.31% of its industry peers.
EWL's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 27.73% | ||
| PM (TTM) | 23.25% | ||
| GM | 78.19% |
OM growth 3Y-5.94%
OM growth 5Y-1.04%
PM growth 3Y38.76%
PM growth 5Y26.09%
GM growth 3Y1.43%
GM growth 5Y1.33%
2. Health
2.1 Basic Checks
EWL has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, EWL has less shares outstanding
The number of shares outstanding for EWL has been reduced compared to 5 years ago.
EWL has a better debt/assets ratio than last year.
2.2 Solvency
EWL has an Altman-Z score of 12.56. This indicates that EWL is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 12.56, EWL belongs to the top of the industry, outperforming 95.38% of the companies in the same industry.
EWL has a debt to FCF ratio of 0.75. This is a very positive value and a sign of high solvency as it would only need 0.75 years to pay back of all of its debts.
EWL has a better Debt to FCF ratio (0.75) than 90.77% of its industry peers.
EWL has a Debt/Equity ratio of 0.06. This is a healthy value indicating a solid balance between debt and equity.
EWL's Debt to Equity ratio of 0.06 is amongst the best of the industry. EWL outperforms 84.62% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.06 | ||
| Debt/FCF | 0.75 | ||
| Altman-Z | 12.56 |
ROIC/WACC1.01
WACC9.75%
2.3 Liquidity
EWL has a Current Ratio of 4.00. This indicates that EWL is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 4.00, EWL belongs to the best of the industry, outperforming 90.77% of the companies in the same industry.
EWL has a Quick Ratio of 3.29. This indicates that EWL is financially healthy and has no problem in meeting its short term obligations.
EWL's Quick ratio of 3.29 is amongst the best of the industry. EWL outperforms 89.23% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 4 | ||
| Quick Ratio | 3.29 |
3. Growth
3.1 Past
The earnings per share for EWL have decreased by -3.75% in the last year.
The Earnings Per Share has been growing slightly by 7.13% on average over the past years.
The Revenue has been growing slightly by 4.67% in the past year.
The Revenue has been growing slightly by 4.58% on average over the past years.
EPS 1Y (TTM)-3.75%
EPS 3Y5.52%
EPS 5Y7.13%
EPS Q2Q%0%
Revenue 1Y (TTM)4.67%
Revenue growth 3Y1.3%
Revenue growth 5Y4.58%
Sales Q2Q%14.67%
3.2 Future
Based on estimates for the next years, EWL will show a quite strong growth in Earnings Per Share. The EPS will grow by 9.50% on average per year.
Based on estimates for the next years, EWL will show a quite strong growth in Revenue. The Revenue will grow by 8.55% on average per year.
EPS Next Y1.51%
EPS Next 2Y6.17%
EPS Next 3Y7.9%
EPS Next 5Y9.5%
Revenue Next Year4.63%
Revenue Next 2Y7.13%
Revenue Next 3Y8.01%
Revenue Next 5Y8.55%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
EWL is valuated quite expensively with a Price/Earnings ratio of 33.49.
EWL's Price/Earnings ratio is in line with the industry average.
EWL is valuated rather expensively when we compare the Price/Earnings ratio to 27.17, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 29.18, the valuation of EWL can be described as expensive.
Compared to the rest of the industry, the Price/Forward Earnings ratio of EWL is on the same level as its industry peers.
The average S&P500 Price/Forward Earnings ratio is at 23.79. EWL is valued slightly more expensive when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 33.49 | ||
| Fwd PE | 29.18 |
4.2 Price Multiples
EWL's Enterprise Value to EBITDA is on the same level as the industry average.
The rest of the industry has a similar Price/Free Cash Flow ratio as EWL.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 62.54 | ||
| EV/EBITDA | 25.5 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
EWL has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)22.14
PEG (5Y)4.7
EPS Next 2Y6.17%
EPS Next 3Y7.9%
5. Dividend
5.1 Amount
No dividends for EWL!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
FRA:EWL (1/6/2026, 7:00:00 PM)
73.34
+1.48 (+2.06%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners89.94%
Inst Owner ChangeN/A
Ins Owners0.11%
Ins Owner ChangeN/A
Market Cap42.56B
Revenue(TTM)5.88B
Net Income(TTM)1.37B
Analysts79.05
Price Target81.68 (11.37%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.01%
Min EPS beat(2)4.4%
Max EPS beat(2)9.63%
EPS beat(4)4
Avg EPS beat(4)5.38%
Min EPS beat(4)3.4%
Max EPS beat(4)9.63%
EPS beat(8)5
Avg EPS beat(8)2.27%
EPS beat(12)6
Avg EPS beat(12)1.21%
EPS beat(16)7
Avg EPS beat(16)-0.18%
Revenue beat(2)1
Avg Revenue beat(2)0.37%
Min Revenue beat(2)-0.12%
Max Revenue beat(2)0.85%
Revenue beat(4)1
Avg Revenue beat(4)-0.56%
Min Revenue beat(4)-2.1%
Max Revenue beat(4)0.85%
Revenue beat(8)1
Avg Revenue beat(8)-2.7%
Revenue beat(12)2
Avg Revenue beat(12)-2.12%
Revenue beat(16)2
Avg Revenue beat(16)-2.48%
PT rev (1m)0.46%
PT rev (3m)6.59%
EPS NQ rev (1m)-0.06%
EPS NQ rev (3m)0.81%
EPS NY rev (1m)0.07%
EPS NY rev (3m)3.32%
Revenue NQ rev (1m)0.13%
Revenue NQ rev (3m)0.19%
Revenue NY rev (1m)0.03%
Revenue NY rev (3m)0.94%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 33.49 | ||
| Fwd PE | 29.18 | ||
| P/S | 8.5 | ||
| P/FCF | 62.54 | ||
| P/OCF | 49.18 | ||
| P/B | 4.9 | ||
| P/tB | 6.84 | ||
| EV/EBITDA | 25.5 |
EPS(TTM)2.19
EY2.99%
EPS(NY)2.51
Fwd EY3.43%
FCF(TTM)1.17
FCFY1.6%
OCF(TTM)1.49
OCFY2.03%
SpS8.63
BVpS14.97
TBVpS10.71
PEG (NY)22.14
PEG (5Y)4.7
Graham Number27.16
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.31% | ||
| ROE | 13.4% | ||
| ROCE | 13.97% | ||
| ROIC | 9.83% | ||
| ROICexc | 14.65% | ||
| ROICexgc | 23.24% | ||
| OM | 27.73% | ||
| PM (TTM) | 23.25% | ||
| GM | 78.19% | ||
| FCFM | 13.59% |
ROA(3y)21.77%
ROA(5y)18.87%
ROE(3y)29.68%
ROE(5y)26.56%
ROIC(3y)12.44%
ROIC(5y)13.58%
ROICexc(3y)16.13%
ROICexc(5y)17.4%
ROICexgc(3y)22.87%
ROICexgc(5y)24.4%
ROCE(3y)17.66%
ROCE(5y)19.29%
ROICexgc growth 3Y-5.47%
ROICexgc growth 5Y-8.01%
ROICexc growth 3Y-11.82%
ROICexc growth 5Y-8.6%
OM growth 3Y-5.94%
OM growth 5Y-1.04%
PM growth 3Y38.76%
PM growth 5Y26.09%
GM growth 3Y1.43%
GM growth 5Y1.33%
F-Score6
Asset Turnover0.44
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.06 | ||
| Debt/FCF | 0.75 | ||
| Debt/EBITDA | 0.33 | ||
| Cap/Depr | 138.79% | ||
| Cap/Sales | 3.69% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 56.86% | ||
| Profit Quality | 58.45% | ||
| Current Ratio | 4 | ||
| Quick Ratio | 3.29 | ||
| Altman-Z | 12.56 |
F-Score6
WACC9.75%
ROIC/WACC1.01
Cap/Depr(3y)185.14%
Cap/Depr(5y)236.01%
Cap/Sales(3y)5.48%
Cap/Sales(5y)6.41%
Profit Quality(3y)37.92%
Profit Quality(5y)57.13%
High Growth Momentum
Growth
EPS 1Y (TTM)-3.75%
EPS 3Y5.52%
EPS 5Y7.13%
EPS Q2Q%0%
EPS Next Y1.51%
EPS Next 2Y6.17%
EPS Next 3Y7.9%
EPS Next 5Y9.5%
Revenue 1Y (TTM)4.67%
Revenue growth 3Y1.3%
Revenue growth 5Y4.58%
Sales Q2Q%14.67%
Revenue Next Year4.63%
Revenue Next 2Y7.13%
Revenue Next 3Y8.01%
Revenue Next 5Y8.55%
EBIT growth 1Y4.68%
EBIT growth 3Y-4.72%
EBIT growth 5Y3.49%
EBIT Next Year13%
EBIT Next 3Y12.27%
EBIT Next 5Y12.76%
FCF growth 1Y1.45%
FCF growth 3Y-42.99%
FCF growth 5Y-22.01%
OCF growth 1Y-2.42%
OCF growth 3Y-32.1%
OCF growth 5Y-14.39%
EDWARDS LIFESCIENCES CORP / EWL.DE FAQ
Can you provide the ChartMill fundamental rating for EDWARDS LIFESCIENCES CORP?
ChartMill assigns a fundamental rating of 7 / 10 to EWL.DE.
What is the valuation status of EDWARDS LIFESCIENCES CORP (EWL.DE) stock?
ChartMill assigns a valuation rating of 2 / 10 to EDWARDS LIFESCIENCES CORP (EWL.DE). This can be considered as Overvalued.
What is the profitability of EWL stock?
EDWARDS LIFESCIENCES CORP (EWL.DE) has a profitability rating of 8 / 10.
What are the PE and PB ratios of EDWARDS LIFESCIENCES CORP (EWL.DE) stock?
The Price/Earnings (PE) ratio for EDWARDS LIFESCIENCES CORP (EWL.DE) is 33.49 and the Price/Book (PB) ratio is 4.9.